Company Profiles

driven by the PitchBook Platform

Ventria Bioscience

Ventria Bioscience
2001 FOUNDED
PRIVATE STATUS
11-50 EMPLOYEES
Grant LATEST DEAL TYPE
$731k LATEST DEAL AMOUNT
4 INVESTORS
Description

Developer of life-saving medicines targeting inflammatory, infectious and gastrointestinal diseases. The company produces medicinal products that are enabled by ExpressTec, a breakthrough in biomanufacturing that is meant to enable global access and affordability. A division of the company makes and sells animal-component-free cell culture reagents and designs animal-component-free cell culture media formulations for cell-based vaccines, cellular therapies and biomanufacturing.

Website:
Ownership Status
Privately Held (no backing)
Financing Status
Corporation
Primary Industry
Pharmaceuticals
Other Industries
Biotechnology
Primary Office
2718 Industrial Drive
Junction City, KS 66441
United States
+1 (800) 916-8311
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Ventria Bioscience’s full profile, request a free trial.

Ventria Bioscience Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Grant 01-Jan-2014 $731k Completed Generating Revenue
5. Grant 04-Sep-2012 00.000 Completed Generating Revenue
4. Grant 01-Jan-2010 00.000 Completed Generating Revenue
3. Grant 12-Mar-2007 000.00 Completed Generating Revenue
2. Grant 01-Jan-2007 $100k Completed Generating Revenue
1. Grant 01-Jan-2006 $503k Completed Generating Revenue
To view this company’s complete deal history including valuation and funding request access »

Ventria Bioscience Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Kansas Bioscience Authority Government 000 0000 000000 0
National Institute Of Allergy and Infectious Diseases Government 000 0000 000000 0
National Institutes of Health Government 000 0000 000000 0
U.S. Department of Health and Human Services Government 000 0000 000000 0

Ventria Bioscience Executive Team (5)

Name Title Board
Seat
Contact
Info
Scott Deeter President, Chief Executive Officer & Board Member
Patrick Smith Director, Quality Assurance
Randall Alfano Ph.D Vice President of InVitria Product Development
Vladimir Akoyev Ph.D Vice President of Manufacturing Sciences
Seymour Fein MD Chief Medical Officer

Ventria Bioscience Board Members (10)

Name Representing Role Since Contact
Info
Pablo Valenzuela Ph.D Self Board Member 000 0000
Scott Deeter Ventria Bioscience President, Chief Executive Officer & Board Member 000 0000
Thomas Urban Jr. Self Board Member 000 0000
William Crouse Self Board Member 000 0000
William Rutter Ventria Bioscience Board Member 000 0000

5 Former Board Members

You’re viewing 5 of 10 board members. Get the full list »